Shin Dong H, Vandenbelt Scott M, Kim Paul H, Gross Jason P, Keole Nandita S, Lee Sang H, Birt Catherine M, Reed Steven Y
Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan 48201-1423, USA.
Am J Ophthalmol. 2002 Jan;133(1):40-7. doi: 10.1016/s0002-9394(01)01285-5.
To investigate the long-term incidence of posterior capsular opacification after phacoemulsification compared with phacotrabeculectomy with or without adjunctive subconjunctival mitomycin C.
This was a retrospectively conducted long-term, observational, case-control study. One hundred eyes of 100 cataract patients who underwent phacoemulsification and posterior chamber intraocular lens implantation and 100 eyes of 100 primary open-angle glaucoma patients with cataract that underwent phacotrabeculectomy and posterior chamber intraocular lens implantation, matched with respect to age, intraocular lens type, prevalence of diabetes mellitus, and length of follow-up. The main outcome measure was the rate of clinically significant posterior capsular opacification as determined by slit-lamp biomicroscopy and necessity to perform neodynium:yttrium aluminum garnet (Nd:YAG) capsulotomy and as calculated by Kaplan-Meier survival analysis. Postoperative visual acuity and maintenance of intraocular pressure control were also measured.
There was no significant difference in the rate of posterior capsular opacification requiring Nd:YAG capsulotomy between the phacoemulsification and phacotrabeculectomy groups (P =.77). However, a significant difference in the rate of posterior capsular opacification was found between those patients without diabetes mellitus and those with a preoperative diagnosis of diabetes mellitus (P =.016). Also, survival analysis comparing use of mitomycin C with no use of mitomycin C in the phacotrabeculectomy group showed a higher survival in the mitomycin C subgroup (P =.03).
There was no significant difference in long-term posterior capsular opacification between phacoemulsification and phacotrabeculectomy in the study population. Intraoperative, adjunctive use of mitomycin C in the phacotrabeculectomy group and the presence of diabetes mellitus in the overall patients were beneficial (protective) factors against posterior capsular opacification.
比较超声乳化白内障吸除术与联合或不联合结膜下丝裂霉素C的小梁切除术,研究超声乳化白内障吸除术后后囊膜混浊的长期发生率。
这是一项回顾性长期观察性病例对照研究。100例接受超声乳化白内障吸除术及后房型人工晶状体植入术的白内障患者的100只眼,以及100例患有白内障的原发性开角型青光眼患者接受小梁切除术及后房型人工晶状体植入术的100只眼,两组在年龄、人工晶状体类型、糖尿病患病率及随访时间方面相匹配。主要观察指标为通过裂隙灯生物显微镜检查确定的具有临床意义的后囊膜混浊发生率,以及进行钕:钇铝石榴石(Nd:YAG)后囊膜切开术的必要性,并通过Kaplan-Meier生存分析计算得出。同时还测量了术后视力及眼压控制情况。
超声乳化白内障吸除术组与小梁切除术组之间,需要进行Nd:YAG后囊膜切开术的后囊膜混浊发生率无显著差异(P = 0.77)。然而发现,无糖尿病患者与术前诊断为糖尿病的患者之间后囊膜混浊发生率存在显著差异(P = 0.016)。此外,小梁切除术组中使用丝裂霉素C与未使用丝裂霉素C的生存分析显示,丝裂霉素C亚组的生存率更高(P = 0.03)。
在本研究人群中,超声乳化白内障吸除术与小梁切除术在长期后囊膜混浊方面无显著差异。小梁切除术组术中辅助使用丝裂霉素C以及总体患者中糖尿病的存在是预防后囊膜混浊的有益(保护)因素。